Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
The global Gene Fragment market was valued at US$ 263.8 million in 2023 and is anticipated to reach US$ 566.5 million by 2030, witnessing a CAGR of 11.4% during the forecast period 2024-2030.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
This report aims to provide a comprehensive presentation of the global market for Gene Fragment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Fragment.
Report Scope
The Gene Fragment market size, estimations, and forecasts are provided in terms of sales volume (Million bp) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Fragment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Fragment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
Segment by Type
0-999 bp
1000-1999 bp
2000-3999 bp
4000+ bp
Segment by Application
CRISPR-based Genome Editing
Antibody Engineering
Cloning Process
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gene Fragment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gene Fragment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Gene Fragment 麻豆原创 Overview
1.1 Product Overview and Scope of Gene Fragment
1.2 Gene Fragment Segment by Type
1.2.1 Global Gene Fragment 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 0-999 bp
1.2.3 1000-1999 bp
1.2.4 2000-3999 bp
1.2.5 4000+ bp
1.3 Gene Fragment Segment by Application
1.3.1 Global Gene Fragment 麻豆原创 Value by Application: (2024-2030)
1.3.2 CRISPR-based Genome Editing
1.3.3 Antibody Engineering
1.3.4 Cloning Process
1.3.5 Others
1.4 Global Gene Fragment 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Gene Fragment Revenue 2019-2030
1.4.2 Global Gene Fragment Sales 2019-2030
1.4.3 Global Gene Fragment 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gene Fragment 麻豆原创 Competition by Manufacturers
2.1 Global Gene Fragment Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Gene Fragment Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Gene Fragment Average Price by Manufacturers (2019-2024)
2.4 Global Gene Fragment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gene Fragment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gene Fragment, Product Type & Application
2.7 Gene Fragment 麻豆原创 Competitive Situation and Trends
2.7.1 Gene Fragment 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gene Fragment Players 麻豆原创 Share by Revenue
2.7.3 Global Gene Fragment 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gene Fragment Retrospective 麻豆原创 Scenario by Region
3.1 Global Gene Fragment 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gene Fragment Global Gene Fragment Sales by Region: 2019-2030
3.2.1 Global Gene Fragment Sales by Region: 2019-2024
3.2.2 Global Gene Fragment Sales by Region: 2025-2030
3.3 Global Gene Fragment Global Gene Fragment Revenue by Region: 2019-2030
3.3.1 Global Gene Fragment Revenue by Region: 2019-2024
3.3.2 Global Gene Fragment Revenue by Region: 2025-2030
3.4 North America Gene Fragment 麻豆原创 Facts & Figures by Country
3.4.1 North America Gene Fragment 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gene Fragment Sales by Country (2019-2030)
3.4.3 North America Gene Fragment Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gene Fragment 麻豆原创 Facts & Figures by Country
3.5.1 Europe Gene Fragment 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gene Fragment Sales by Country (2019-2030)
3.5.3 Europe Gene Fragment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gene Fragment 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Gene Fragment 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gene Fragment Sales by Country (2019-2030)
3.6.3 Asia Pacific Gene Fragment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gene Fragment 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Gene Fragment 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gene Fragment Sales by Country (2019-2030)
3.7.3 Latin America Gene Fragment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gene Fragment 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Gene Fragment 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gene Fragment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gene Fragment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gene Fragment Sales by Type (2019-2030)
4.1.1 Global Gene Fragment Sales by Type (2019-2024)
4.1.2 Global Gene Fragment Sales by Type (2025-2030)
4.1.3 Global Gene Fragment Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Gene Fragment Revenue by Type (2019-2030)
4.2.1 Global Gene Fragment Revenue by Type (2019-2024)
4.2.2 Global Gene Fragment Revenue by Type (2025-2030)
4.2.3 Global Gene Fragment Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Gene Fragment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gene Fragment Sales by Application (2019-2030)
5.1.1 Global Gene Fragment Sales by Application (2019-2024)
5.1.2 Global Gene Fragment Sales by Application (2025-2030)
5.1.3 Global Gene Fragment Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Gene Fragment Revenue by Application (2019-2030)
5.2.1 Global Gene Fragment Revenue by Application (2019-2024)
5.2.2 Global Gene Fragment Revenue by Application (2025-2030)
5.2.3 Global Gene Fragment Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Gene Fragment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Integrated DNA Technologies
6.1.1 Integrated DNA Technologies Corporation Information
6.1.2 Integrated DNA Technologies Description and Business Overview
6.1.3 Integrated DNA Technologies Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Integrated DNA Technologies Gene Fragment Product Portfolio
6.1.5 Integrated DNA Technologies Recent Developments/Updates
6.2 Thermo Scientific
6.2.1 Thermo Scientific Corporation Information
6.2.2 Thermo Scientific Description and Business Overview
6.2.3 Thermo Scientific Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Scientific Gene Fragment Product Portfolio
6.2.5 Thermo Scientific Recent Developments/Updates
6.3 Eurofins Scientific
6.3.1 Eurofins Scientific Corporation Information
6.3.2 Eurofins Scientific Description and Business Overview
6.3.3 Eurofins Scientific Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eurofins Scientific Gene Fragment Product Portfolio
6.3.5 Eurofins Scientific Recent Developments/Updates
6.4 GenScript Biotech
6.4.1 GenScript Biotech Corporation Information
6.4.2 GenScript Biotech Description and Business Overview
6.4.3 GenScript Biotech Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GenScript Biotech Gene Fragment Product Portfolio
6.4.5 GenScript Biotech Recent Developments/Updates
6.5 Azenta Life Sciences
6.5.1 Azenta Life Sciences Corporation Information
6.5.2 Azenta Life Sciences Description and Business Overview
6.5.3 Azenta Life Sciences Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Azenta Life Sciences Gene Fragment Product Portfolio
6.5.5 Azenta Life Sciences Recent Developments/Updates
6.6 Twist Bioscience
6.6.1 Twist Bioscience Corporation Information
6.6.2 Twist Bioscience Description and Business Overview
6.6.3 Twist Bioscience Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Twist Bioscience Gene Fragment Product Portfolio
6.6.5 Twist Bioscience Recent Developments/Updates
6.7 Synbio Technologies
6.6.1 Synbio Technologies Corporation Information
6.6.2 Synbio Technologies Description and Business Overview
6.6.3 Synbio Technologies Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Synbio Technologies Gene Fragment Product Portfolio
6.7.5 Synbio Technologies Recent Developments/Updates
6.8 Bio Basic
6.8.1 Bio Basic Corporation Information
6.8.2 Bio Basic Description and Business Overview
6.8.3 Bio Basic Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio Basic Gene Fragment Product Portfolio
6.8.5 Bio Basic Recent Developments/Updates
6.9 BiOligo Biotechnology
6.9.1 BiOligo Biotechnology Corporation Information
6.9.2 BiOligo Biotechnology Description and Business Overview
6.9.3 BiOligo Biotechnology Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BiOligo Biotechnology Gene Fragment Product Portfolio
6.9.5 BiOligo Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gene Fragment Industry Chain Analysis
7.2 Gene Fragment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gene Fragment Production Mode & Process
7.4 Gene Fragment Sales and 麻豆原创ing
7.4.1 Gene Fragment Sales Channels
7.4.2 Gene Fragment Distributors
7.5 Gene Fragment Customers
8 Gene Fragment 麻豆原创 Dynamics
8.1 Gene Fragment Industry Trends
8.2 Gene Fragment 麻豆原创 Drivers
8.3 Gene Fragment 麻豆原创 Challenges
8.4 Gene Fragment 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Integrated DNA Technologies
Thermo Scientific
Eurofins Scientific
GenScript Biotech
Azenta Life Sciences
Twist Bioscience
Synbio Technologies
Bio Basic
BiOligo Biotechnology
听
听
*If Applicable.
